Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?

Blumenfeld Z.

J Clin Oncol. 2018 Jul 1;36(19):1895-1897. doi: 10.1200/JCO.2018.78.9347. Epub 2018 May 2. No abstract available.

PMID:
29718789
2.

Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?

Rodriguez-Wallberg K, Turan V, Munster P, Oktay K.

Ann Oncol. 2016 Feb;27(2):357. doi: 10.1093/annonc/mdv554. Epub 2015 Nov 25. No abstract available.

3.

Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.

Turner NH, Partridge A, Sanna G, Di Leo A, Biganzoli L.

Ann Oncol. 2013 Sep;24(9):2224-35. doi: 10.1093/annonc/mdt196. Epub 2013 May 24. Review.

PMID:
23709175
4.

Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.

Hickman LC, Valentine LN, Falcone T.

Am J Obstet Gynecol. 2016 Oct;215(4):415-22. doi: 10.1016/j.ajog.2016.06.053. Epub 2016 Jul 13. Review.

PMID:
27422055
5.

Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

Lambertini M, Cinquini M, Moschetti I, Peccatori FA, Anserini P, Valenzano Menada M, Tomirotti M, Del Mastro L.

Eur J Cancer. 2017 Jan;71:25-33. doi: 10.1016/j.ejca.2016.10.034. Epub 2016 Dec 9. Review.

PMID:
27940355
6.

Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.

Blumenfeld Z, Zur H, Dann EJ.

Oncologist. 2015 Nov;20(11):1283-9. doi: 10.1634/theoncologist.2015-0223. Epub 2015 Oct 13.

7.

Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.

Blumenfeld Z, Evron A.

Expert Opin Pharmacother. 2015 May;16(7):1009-20. doi: 10.1517/14656566.2015.1031654. Epub 2015 Mar 31. Review.

PMID:
25826240
8.

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.

Lambertini M, Fontana V, Massarotti C, Poggio F, Dellepiane C, Iacono G, Abate A, Miglietta L, Ferreccio C, Pescio MC, Conte B, Blondeaux E, Bighin C, D'Alonzo A, Vaglica M, Zanardi E, Boccardo F, Ballestrero A, Anserini P, Del Mastro L.

Breast. 2018 Oct;41:51-56. doi: 10.1016/j.breast.2018.06.012. Epub 2018 Jun 22.

PMID:
30007268
9.

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Del Mastro L, Lambertini M.

Oncologist. 2015 Nov;20(11):1233-5. doi: 10.1634/theoncologist.2015-0373. Epub 2015 Oct 13. No abstract available.

10.

Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.

Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC.

Ultrasound Obstet Gynecol. 2018 Jan;51(1):77-86. doi: 10.1002/uog.18934. Epub 2017 Dec 1. Review.

11.

Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.

Conte B, Del Mastro L.

Minerva Ginecol. 2017 Aug;69(4):350-356. doi: 10.23736/S0026-4784.17.04067-9. Epub 2017 Apr 10. Review.

PMID:
28398024
12.

Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.

Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, Marques RJ.

JAMA Oncol. 2016 Jan;2(1):65-73. doi: 10.1001/jamaoncol.2015.3251. Review.

13.

Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Elgindy E, Sibai H, Abdelghani A, Mostafa M.

Obstet Gynecol. 2015 Jul;126(1):187-95. doi: 10.1097/AOG.0000000000000905. Review.

PMID:
26241272
14.

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.

Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L.

Ann Oncol. 2015 Dec;26(12):2408-19. doi: 10.1093/annonc/mdv374. Epub 2015 Sep 7. Review.

PMID:
26347105
15.

Endocrine prevention of chemotherapy-induced ovarian failure.

Blumenfeld Z, Evron A.

Curr Opin Obstet Gynecol. 2016 Aug;28(4):223-9. doi: 10.1097/GCO.0000000000000278. Review.

PMID:
27253235
16.

Fertility preservation and breast cancer: A complex problem.

Munster PN.

Oncology (Williston Park). 2013 Jun;27(6):533-9. Review.

17.

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y.

J Clin Oncol. 2016 Aug 1;34(22):2568-74. doi: 10.1200/JCO.2015.65.8864. Epub 2016 May 23.

PMID:
27217453
18.

Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Lambertini M, Poggio F, Levaggi A, Del Mastro L.

Obstet Gynecol. 2015 Oct;126(4):901. doi: 10.1097/AOG.0000000000001076. No abstract available.

PMID:
26393449
19.

Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.

Falcone T, Farrell RM, Moore HC.

Obstet Gynecol. 2015 Oct;126(4):899-900. doi: 10.1097/AOG.0000000000001074. No abstract available.

PMID:
26393447
20.

Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.

Lambertini M, Horicks F, Del Mastro L, Partridge AH, Demeestere I.

Cancer Treat Rev. 2019 Jan;72:65-77. doi: 10.1016/j.ctrv.2018.11.006. Epub 2018 Dec 1. Review.

PMID:
30530271

Supplemental Content

Support Center